The biology of glycoprotein IIb-IIIa

Coronary Artery Disease

Volumn 10, Issue 8, 1999, Pages 547-551

  Plow, Edward F ^a   Byzova, Tatiana ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Integrin; Platelets; Thrombosis; (IIb) 3

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; INTEGRIN; LIGAND; MEMBRANE PROTEIN; TIROFIBAN;

BLEEDING; CARDIOVASCULAR DISEASE; GLANZMANN DISEASE; HEART INFARCTION; HEMOSTASIS; HOST RESISTANCE; HUMAN; MEGAKARYOCYTE; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; STROKE; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 0032762593     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199912000-00002     Document Type: Short Survey

References (37)

1. 1 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71:831-843.
2. 3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasis. Int J Cancer 1993; 54:338-347.
3. 3 Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88:907-914.
4. 4 Wencel-Drake JD, Plow EF, Kunicki TJ, Woods VL, Keller DM, Ginsberg MH. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986; 124:324-334.
5. 5 Wencel-Drake JD. Plasma membrane GPIIb/IIIa. Evidence for a cycling receptor pool. Am J Pathol 1990; 136:61-70.
6. 3 (glycoprotein IIb-IIIa). Blood 1993; 82:135-138.
7. 7 Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25. A review that provides an overview of the integrin family of adhesion receptors and their biology.
8. 3: a ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem 1996; 271:6017-6026.
9. 3. J Biol Chem 1994; 269:4641-4647.
10. 10 Loftus JC, Liddington RC. Perspectives Series: Cell adhesion in vascular biology. New insights into integrin-ligand interaction. J Clin Invest 1997; 99:2302-2306.
11. 11 Fitzgerald LA, Poncz M, Steiner B, Rall SC Jr, Bennett JS, Phillips DR. Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry 1987; 26:8158-8165.
12. 3-(GPIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 1996; 271:10811-10815.
13. 13 Hillery CA, Smyth SS, Parise LV. Phosphorylation of human platelet glycoprotein IIIa (GPIIIa). Dissociation from fibrinogen receptor activation and phosphorylation of GPIIIa in vitro. J Biol Chem 1991; 266:14663-14669.
14. 14 O'Toole TE, Ylanne J, Culley BM. Regulation of integrin affinity states through an NPXY motif in the β subunit cytoplasmic domain. J Biol Chem 1995; 270:8553-8558.
15. 3 (platelet GPIIb-IIIa). Biochemistry 1994; 33:7701-7708.
16. 16 Valentin N, Newman PJ. Human platelet alloantigens. Curr Opin Hematol 1994; 1:381-387.
17. 17 Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC. et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334:1090-1099.
18. 18 Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpainter K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombus. Lancet 1997; 349:305-388.
19. 19 Nurden AT, Caen JP. An abnormal glycoprotein pattern in three cases in Glanzmann's thrombasthenia. Br J Haematol 1974; 28:253-260.
20. 20 Phillips DR, Agin PP. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60:535-545.
21. 21 Plow EF, D'Souza SE, Ginsberg MH. Ligand binding to GPIIb-IIIa: a status report. Semin Thromb Hemost 1992; 18:324-332. Review of glycoprotein IIb/IIIa structure and function, emphasizing the basis for ligand recognition by this receptor
22. 22 Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Biol 1995; 11:549-599. A comprehensive review of signaling via integrins.
23. 3. J Cell Biol 1998; 141:1685-1695.
24. 24 Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70:119-123.
25. 25 Marguerie GA, Edgington TS, Plow EF. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980; 255:154-161.
26. 3) and its ligands. J Lab Clin Med 1992; 120:198-204. This review presents a discussion of the post-receptor occupancy events that occur upon ligand engagement of glycoprotein IIb/IIIa.
27. 27 Shattil SJ, Ginsberg MH. Perspective Series: Cell adhesion in vascular biology. Integrin signaling in vascular biology. J Clin Invest 1997; 100:S91-S95. A recent consideration of the role of integrins in signal transduction, in both inside-out and outside-in signaling events.
28. 28 Plow EF, Marguerie GA, Ginsberg M. Fibrinogen, fibrinogen receptors and the peptides that inhibit these interactions. Biochem Pharmacol 1987; 36:4035-4040. A review of the fibrinogen-derived peptides that inhibit ligand binding to glycoprotein IIb/IIIa. These peptides were the starting points for several of the glycoprotein IIb/IIIa antagonists.
29. 29 Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Biol 1996; 12:697-715.
30. 30 Farrell DH, Thiagarajan P, Chung DW, Davie EW. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89:10729-10732.
31. 3. EMBO J 1996; 15:5760-5771.
32. 32 Rooney MM, Parise LV, Lord ST. Dissecting clot retraction and platelet aggregation. J Biol Chem 1996; 271:8553-8555.
33. 3 binds prothrombin and influences its activation. J Biol Chem 1997; 272:27183-27188.
34. 3. In: Sasahara AA, Loscalzo J, editors. New therapeutic agents in thrombosis and thrombolysis. New York: Marcel Dekker, Inc.; 1997. pp. 291-313.
35. 35 Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, et al. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus M. Barbouri. J Biol Chem 1991; 266:9359-9362.
36. 36 Barrett JS, Murphy G, Peerlinck K, De Lepeleire I, Gould RJ, Panebianco D, et al. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clin Pharmacol Ther 1994; 56:377-388.
37. 37 Badorc A, Bordes MF, DeCointet P, Savi P, Bernat A, Lale A, et al. New orally active non-peptide fibrinogen receptor (GPIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl)imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent. J Med Chem 1997; 40:3393-3401.